Big Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery
Bay Area biotech SonoThera is bubbling to a clinical boil after raising a $125 million series B with the backing of some of the biggest names in pharma. Vida Ventures led the raise, with the venture arms of UCB, Bayer, Otsuka Pharmaceutical and Johnson & Johnson all pitching in to support SonoThera’s unique delivery system for [...]









